Ex vivo approaches to predicting oral pharmacokinetics in humans

被引：8

作者：

Stewart, BH ^{[1
]}

Wang, Y ^{[1
]}

Surendran, N ^{[1
]}

机构：

[1] Parke Davis Pharmaceut Res, Ann Arbor, MI 48105 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35 | 2000年 / 35卷

关键词：

D O I：

10.1016/S0065-7743(00)35028-X

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：299 / 307

页数：9

共 96 条

[91]

Witherow LE, 1999, J PHARMACOL EXP THER, V290, P58

[92] Immobilized artificial membranes - Screens for drug membrane interactions [J].

Yang, CY ;

Cai, SJ ;

Liu, HL ;

Pidgeon, C .

ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :229-256

[93] Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds [J].

Yazdanian, M ;

Glynn, SL ;

Wright, JL ;

Hawi, A .

PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1490-1494

[94] Effects of cholestyramine and parenteral nutrition on hepatic metabolism of lidocaine: A study using isolated rat liver perfusion [J].

Zaman, N ;

Tam, YK ;

Jewel, LD ;

Coutts, RT .

JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1996, 20 (05) :349-356

[95] Characterization of P-glycoprotein mediated transport of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor, across MDR1-MDCK and Caco-2 cell monolayers [J].

Zhang, YC ;

Benet, LZ .

PHARMACEUTICAL RESEARCH, 1998, 15 (10) :1520-1524

[96] KINETICS OF DIAZEPAM METABOLISM IN RAT HEPATIC MICROSOMES AND HEPATOCYTES AND THEIR USE IN PREDICTING IN-VIVO HEPATIC-CLEARANCE [J].

ZOMORODI, K ;

CARLILE, DJ ;

HOUSTON, JB .

XENOBIOTICA, 1995, 25 (09) :907-916

← 1 2 3 4 5 6 7 8 9 10 →